Delta-Fly Pharma, Inc. (TSE: 4598)
Health Care · Biotechnology · JP
¥84.00
-15.15% today · -82.7% 1Y
Delta-Fly Pharma, Inc. (TSE: 4598) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.86M and employs 12 people.
Over the last twelve months the share price has lost 82.7%, trading between 78.00 and 700.00.
Tweenvest scores Delta-Fly Pharma, Inc. across four factors: quality 32/100, value 9/100. Its strongest factor is quality.
4598 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.86M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -134.57
- Dividend yield
- —
- Beta (5Y)
- -0.78
- 52-week high
- ¥700.00
- 52-week low
- ¥78.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.78M
- Employees
- 12
- Next earnings
- —
About Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
- ISIN
- JP3549370009
- Founded
- 2010
- Listed since
- Oct 12, 2018
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MOA Life Plus Co. Ltd.KOSDAQ: A142760 | $8.22M | ₩520.00 | +0.78% |
| NFL Biosciences SAENXTPA: ALNFL | $8.08M | €0.57 | -8.55% |
| Vivesto ABOM: VIVE | $8.06M | Skr7.21 | -3.74% |
| OSR Health, Inc.OTCPK: OSRH | $7.94M | $0.23 | +15.90% |
| OptiBiotix Health PlcAIM: OPTI | $7.79M | £0.06 | -4.24% |
| Bolt Biotherapeutics, Inc.NasdaqCM: BOLT | $7.71M | $4.00 | -2.68% |
| Soligenix, Inc.NasdaqCM: SNGX | $7.69M | $0.35 | -2.89% |
| Immuron LimitedASX: IMC | $7.64M | AU$0.03 | -24.44% |
Figures last refreshed Oct 18, 2026.